Arbutus Biopharma Corp Income Taxes Receivable, Current
Arbutus Biopharma Corp (ABUS) had Income Taxes Receivable, Current of $291.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-06.
Discontinued › Notes
us-gaap:IncomeTaxesReceivable · last filed 2019-05-06
- 2013-12-31: Income Taxes Receivable, Current 40.20K CAD.
- 2012-12-31: Income Taxes Receivable, Current 9.88K CAD; Income Taxes Receivable, Current as first filed 9.82K CAD.
- 2011-12-31: Income Taxes Receivable, Current 331.03K CAD.
- 2010-12-31: Income Taxes Receivable, Current 403.58K CAD.
CAD
| Period end | Income Taxes Receivable, Current | Income Taxes Receivable, Current as first filed |
|---|---|---|
| 2013-12-31 | 40.20K CAD 10-K · filed 2014-03-28 | |
| 2012-12-31 | 9.88K CAD 10-K · filed 2014-03-28 | 9.82K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 331.03K CAD 20-F · filed 2013-03-27 | |
| 2010-12-31 | 403.58K CAD 20-F · filed 2012-03-27 |
USD
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2019-03-31 | $291.00K 10-Q · filed 2019-05-06 |
| 2018-12-31 | $389.00K 10-Q · filed 2019-05-06 |
| 2018-09-30 | $342.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $342.00K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $342.00K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $340.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $160.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $160.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $308.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $293.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | $148.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $148.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $246.00K 10-Q · filed 2016-05-04 |
| 2015-12-31 | $246.00K 10-K · filed 2017-03-22 |
| 2015-09-30 | $52.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $55.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $79.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $86.00K 10-K · filed 2016-03-09 |
| 2014-09-30 | $38.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $40.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $39.00K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $40.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |